Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posterior quadratus lumborum block with different liposomal bupivacaine concentrations after cesarean section
ChiCTR2400085082Phase 4Not yet recruiting
- Sponsor
- Chongzhou City Maternal and Child Health Hospital
- Start
- Jun 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine in postoperative pain (3 arms), sponsored by Chongzhou City Maternal and Child Health Hospital. Primary endpoint: Duration of postoperative analgesia in each group. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400085082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085082.